Anyai és újszülöttkori B12-vitamin-hiány felismerése kiterjesztett újszülöttkori szuréssel

Papp Ferenc, Rácz Gábor, Lénárt István, Kóbor Jeno, Bereczki Csaba, Karg Eszter, Baráth Ákos

Research output: Article

2 Citations (Scopus)


Introduction: Infant Vitamin B12 deficiency can manifest as a severe neurodegenerative disorder and is usually caused by maternal deficiency due to vegetarian diet or pernicious anaemia. Its early recognition and treatment can prevent potentially serious and irreversible neurologic damage. Biochemically, Vitamin B12 deficiency leads to an accumulation of methylmalonic acid, homocysteine, and propionylcarnitine. Expanded newborn screening using tandem mass spectrometry may identify neonatal and maternal Vitamin B12 deficiency by measurement of propionylcarnitine and other metabolites in the dried blood spot sample of newborns. Aim: To summarize our experiences gained by screening for Vitamin B12 deficiency. Method: Clinical and laboratory data of Vitamin B12-deficient infants diagnosed in Szeged Screening Centre were retrospectively analysed. Results: In Hungary, expanded newborn screening was introduced in 2007. Since then approximately 395 000 newborns were screened in our centre and among them, we identified four newborns with Vitamin B12 deficiency based on their screening results. In three cases an elevated propionylcarnitine level and in the fourth one a low methionine level were indicative of Vitamin B12 deficiency. We also detected an additional Vitamin B12-deficient infant with neurological symptoms at 4 months of age, after a normal newborn screening, because of elevated urinary methylmalon- ic acid concentration. Vitamin B12 deficiency was secondary to maternal autoimmune pernicious anaemia in all the five infants. As a result of the recognized cases the incidence of infant Vitamin B12 deficiency in the East-Hungarian region was 1.26/100 000 births, but the real frequency may be higher. Conslusions: Optimizing the cut off values of current screening parameters and measuring of methylmalonic acid and/or homocysteine in the dried blood spot, as a second tier test, can improve recognition rate of Vitamin B12 deficiency.

Translated title of the contributionMaternal and neonatal Vitamin B12 deficiency detected by expanded newborn screening
Original languageHungarian
Pages (from-to)1909-1918
Number of pages10
JournalOrvosi hetilap
Issue number48
Publication statusPublished - dec. 2017


  • Methylmalonic acid
  • Newborn screening
  • Pernicious anemia
  • Tandem mass spectrometry
  • Vitamin B deficiency

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Anyai és újszülöttkori B<sub>12</sub>-vitamin-hiány felismerése kiterjesztett újszülöttkori szuréssel'. Together they form a unique fingerprint.

  • Cite this